The use of insulin pumps could increase five-fold, and total additional costs to the UK NHS could approach $US11 million annually, as a result of new guidance UK NICE.An abstract is unavailable.doi:10.1097/00008505-200211040-00021Michael
Needle-based delivery systems suit the vast majority of people with type 1 and type 2 diabetes who require insulin. However, a small group may be better suited to a needle-free delivery system. In the UK, GPs can now prescribe, on the NHS, such a needle-free delivery system — sometimes...
The Academic Kidney Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK Richard A. Oram Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA Carmella Evans-Molina Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapoli...
(p. 462.2). choice of insulin. the different types of insulin and their formulations are described under definitions and terminology, p. 476.1. in some countries including the uk the commercially available preparations have been standardised to a single strength containing l 00 units/ml; a ...
intraperitoneal insulin delivery and the combination of contin- uous glucose monitoring with insulin pumps, using algorithms to produce closed-loop systems, herald a new future for insulin delivery. Keywords CGM; continuous glucosemonitoring; continuous subcutaneous insulin infusions; CSII; insulin pumps; ...
objective: Insulin bolus calculators are simple decision support software tools incorporated in most commercially available insulin pumps and some capillary blood glu- cose meters. Although their clinical benefit has been demonstrated, their utilisation has not been widespread and their performance ...
water - 2H20 enriched water; stop-watch symbol; 1 and 2 are blood sample points (venous blood and capillary samples from hyperemic ear lobe); a-c volumetric infusion pumps (a – enriched glucose , b – spare, c – intervention infuser); d-f, infusion syringes (d – insulin, e and...
While countries across the world, notably the USA, continued with pump development, the UK appeared to move away from CSII, following concerns about efficacy and safety, and the potential financial burden on the NHS. In the past decade technology has advanced and modern pumps are now small in...